Relationship of motor symptoms to intellectual deficits in PD
Neurology 33(10): 1390-1391
1983
ISSN/ISBN: 0028-3878 PMID: 6684241 Document Number: 218169
Document emailed within 1 workday
Related Documents
Dickerson, F.B.; Ringel, N.B.; Boronow, J.J. 1991: Neuropsychological deficits in chronic schizophrenics. Relationship with symptoms and behavior Journal of Nervous and Mental Disease 179(12): 744-749Liu, C.; Mao, C. 2014: Exploring new assessment methods to evaluate motor and non-motor symptoms comprehensively and objectively in patients with Parkinson's disease Zhonghua Yi Xue Za Zhi 94(11): 801-803
Joshi, J.B.; Mukherjee, A.; Singh, N.; Varma, S.K. 1973: Residual motor deficits in the lower extremity of adult stroke hemiplegics Neurology India 21(2): 83-87
Pape, K.E.; Kirsch, S.E.; Galil, A.; Boulton, J.E.; White, M.A.; Chipman, M. 1993: Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study Journal of Pediatric Orthopedics 13(5): 628-633
Sasaki, M. 2013: Severe motor and intellectual disabilities and brain death in children No to Hattatsu 45(1): 5-10
Shireen, E.; Pervez, S.; Masroor, M.; Ali, W.B.; Rais, Q.; Khalil, S.; Tariq, A.; Haleem, D.J. 2014: Reversal of haloperidol induced motor deficits in rats exposed to repeated immobilization stress Pakistan Journal of Pharmaceutical Sciences 27(Special Issue 5): 1459-1466
Arai, H.; Yamada, M.; Miyake, S.; Yamashita, S.; Iwamoto, H.; Aida, N.; Hara, M. 1997: Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome No to Hattatsu 29(5): 361-366
Miura, K. 2016: The rewards of working with medicine for patients with severe motor and intellectual disabilities No to Hattatsu 48(1): 5-9
Konishi, T. 2005: Governmental medical and welfare policy for severe motor and intellectual disabilities No to Hattatsu 37(4): 278
Maruyama, K.; Kurahashi, H.; Suzuki, M.; Miura, K.; Kumagai, T. 2012: Survival analysis for patients with severe motor and intellectual disabilities following tracheotomy No to Hattatsu 44(1): 25-28
Ostazewska, J.; Stanikowska, I. 1975: Intellectual efficiency and symptoms of schizoprenic process Psychiatria Polska 09(2): 121-127
Tojo, M. 1997: The effect of "Ueda" method for the treatment of a severe motor and intellectual disabilities syndrome No to Hattatsu 29(5): 401-405
Mizuno, Y.; Ukaji, K. 2005: Usefullness of bronchofiberscopy for difficult intubation in patients with severe motor and intellectual disabilities No to Hattatsu 37(6): 499-504
Okada, M.; Takata, K.; Hoshikawa, T.; Iwabuchi, M.; Miura, Y.; Kawamae, K. 2008: Airway and respiratory management for anesthesia in the patients with severe motor and intellectual disabilities Masui. Japanese Journal of Anesthesiology 57(1): 76-81
Clark, F.; Mailloux, Z.; Parham, L.D.; Primeau, L.A. 1991: Statement: occupational therapy provision for children with learning disabilities and/or mild to moderate perceptual and motor deficits American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 45(12): 1069-1074
Baty, D.E.; Zhang, M.; Li, H.; Erb, C.J.; Adler, M.W.; Ganea, D.; Loftus, C.M.; Jallo, J.I.; Tuma, R.F. 2008: Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury Clinical Neurosurgery 55: 172-177
Mori, N.; Kurosawa, H.; Matsumoto, K.; Ito, A.; Ito, T.; Fujiwara, K.; Kohzuki, M. 2006: Relationships between spinal deformities and respiratory function in patients with severe motor and intellectual disabilities syndrome No to Hattatsu 38(1): 10-14
Mizuno, Y.; Sasazuki, M.; Aibe, M.; Honjo, S. 2009: Study on the etiology and treatment of tracheal granulation tissue in patients with severe motor and intellectual disabilities No to Hattatsu 41(4): 275-278
Suzuki, H.; Akiyama, C. 1997: Clinico-etiological study of forty-five cases of children with severe motor and intellectual disabilities of postnatal origin No to Hattatsu 29(6): 455-459
Bodick, N.C.; Offen, W.W.; Shannon, H.E.; Satterwhite, J.; Lucas, R.; van Lier, R.; Paul, S.M. 1997: The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease Alzheimer Disease and Associated Disorders 11(Suppl 4): S16-S22